Optimized Medical Treatment

DRUG3 trials

Sponsors

ResMed, AbbVie, Sahlgrenska University Hospital

Conditions

Acute Decompensated Heart FailureAdvanced Parkinson's DiseaseIrritable Bowel SyndromeSleep Disordered Breathing

Phase 3

A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)

CompletedNCT02549092

AbbVieAdvanced Parkinson's Disease

Start: 2015-10-26End: 2022-11-18Updated: 2023-11-28

Unknown Phase

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

TerminatedNCT01953874

ResMedAcute Decompensated Heart Failure, Sleep Disordered Breathing

Start: 2013-12-31End: 2015-12-31Updated: 2018-02-28

A Comparison of Three Different Treatment Options for Irritable Bowel Syndrome

CompletedNCT02970591

Sahlgrenska University HospitalIrritable Bowel Syndrome

Start: 2017-01-31End: 2022-04-29Target: 300Updated: 2022-10-27

Related Papers

A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.

2024-04-1842 citations

Effects of Levodopa‐Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study

Parkinson s Disease2022-01-015 citations

The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options

JMIR Research Protocols2021-11-275 citations

Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study

Clinical Nutrition2021-09-0922 citations

Cardiovascular Outcomes With Minute Ventilation–Targeted Adaptive Servo-Ventilation Therapy in Heart Failure

Journal of the American College of Cardiology2017-03-01151 citations